Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

15.77
Delayed Data
As of Feb 21
 -0.70 / -4.25%
Today’s Change
12.25
Today|||52-Week Range
27.02
-12.49%
Year-to-Date

Today’s Trading

Previous close16.47
Today’s open16.31
Day’s range15.64 - 16.60
Volume3,502,341
Average volume (3 months)1,624,120
Market cap$971.1M
Dividend yield--
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+45.08%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.04

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...+0.06+0.30%
INSMInsmed Inc-0.48-3.11%
CORTCorcept Therapeutics...-0.05-0.66%
RGENRepligen Corp-0.54-1.74%
Data as of 4:00pm ET, 02/21/2017

Financials

Last reporting dateFebruary 22, 2017
EPS forecast (this quarter)$0.36
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts


Search for Jobs